Mad Money w/ Jim Cramer
Mad Money w/ Jim Cramer

Apr 20, 2026 · 44 min

AI demand powers market rebound despite geopolitical risk

Mad Money w/ Jim Cramer 4/20/26

The episode tests whether earnings and technology investment can sustain a rapid market recovery while geopolitical uncertainty remains unresolved.

3 key takeaways
  1. 1Strong corporate earnings and AI-driven demand are helping markets absorb geopolitical shocks and higher energy-price concerns.
  2. 2Semiconductor infrastructure, memory demand, and capacity expansion emerge as central drivers of the rally’s strongest performers.
  3. 3Definium Therapeutics makes the case for single-dose psychedelic treatments as regulatory and clinical questions shape psychiatric drug development.

Don't miss

Rob Barrows explains why Definium Therapeutics believes a single-dose psychedelic treatment could change how anxiety and depression are treated.

The brief

Jim Cramer argues that strong earnings and technology demand have helped the market recover sharply despite geopolitical developments involving Iran and concerns about energy prices.

The rally’s leaders point toward AI infrastructure: memory shortages and semiconductor capacity expansion support Nvidia, Micron, Applied Materials, Lam Research, and KLA.

Cramer treats CoreWeave’s debt and volatility as major risks, urges patience with Salesforce, and presents Applied Materials as a more durable semiconductor beneficiary.

Definium Therapeutics CEO Rob Barrows discusses psychedelic-based treatments for anxiety and depression, including clinical measurement, single-dose potential, and approval hurdles.

The episode closes with Cramer defending the charitable trust’s Johnson & Johnson purchase through its drug pipeline, psoriasis treatment, spinoffs, and valuation.

What was said on this episode

42 statements · 27 positive · 8 negative · 3 mixed · 4 neutral

  1. Jim Crameron Kevin WarshPositive2:01

    Kevin Warsh will be appointed Fed chair and push for rate cuts.

    “I expect he'll be appointed. And when he is, he's going to push to cut rates.”

    Listen at 2:01

  2. Jim Crameron Federal Reserve rate cutsPositive2:15

    Kevin Warsh can secure at least one rate cut if the economy stays moderate.

    “As long as the economy doesn't get too strong, I think he can get at least one rate cut.”

    Listen at 2:15

  3. Jim Crameron Federal Reserve policyNegative2:23

    Selling stocks now means opposing expected Federal Reserve policy.

    “if you're selling right now, you are fighting the Fed. Don't fight the Fed.”

    Listen at 2:23

  4. Gasoline prices have become less important to consumers than previously.

    “gasoline simply isn't as important in our lives as they once were.”

    Listen at 3:39

  5. Jim Crameron Hot-rolled steel pricesNeutral4:56

    Hot-rolled steel prices have been unchanged over five years.

    “The price of hot rolled steel, a major grade that's used in autos that Cleveland Cliffs dominates, is unchanged in the last five years.”

    Listen at 4:56

  6. The AI revolution is resilient to geopolitical and fuel-related disruptions.

    “This AI revolution doesn't know anything about Iran, doesn't know anything about bombing, doesn't run on gasoline, and it stops for no one. It's a juggernaut”

    Listen at 5:27

  7. Jim Crameron Apple Inc.Positive5:58

    Tim Cook led Apple to a four-trillion-dollar valuation.

    “Tim has done an amazing job piloting the company to its four trillion dollar perch”

    Listen at 5:58

  8. Jim Crameron Tim CookNeutral6:23

    Tim Cook will remain Apple CEO until September 1.

    “Tim will stay CEO until September 1st.”

    Listen at 6:23

  9. Jim Crameron Anthropic-Amazon Web Services dealPositive7:49

    Anthropic will spend substantially on Amazon Web Services.

    “An amazing deal. Anthropic's going to spend a lot of money on Amazon”

    Listen at 7:49

  10. AI will substantially improve human efficiency.

    “People will be much more efficient.”

    Listen at 8:21

  11. Jim Crameron Iran WarNegative8:52

    A catastrophic Iran event within 48 hours would affect markets.

    “If something catastrophic happens in the next 48 hours, of course it's going to impact the markets.”

    Listen at 8:52

  12. Jim Crameron Iran WarNeutral9:04

    The Iran war will not affect stocks unless it materially affects bonds.

    “Until the war gets bad enough to impact the bomb market, don't expect it to matter to the stock market.”

    Listen at 9:04

  13. General Mills should pursue a combination with another food company.

    “they've got to combine”

    Listen at 9:33

  14. Jim Crameron BerkshireNegative10:22

    Investors should not sell Berkshire Hathaway now.

    “to leave the stock now is a big mistake.”

    Listen at 10:22

  15. Jim Crameron S&P 500Negative12:57

    Extremely overbought markets tend to decline gradually.

    “when you are this overbought, you tend to go down at a pretty easy pace gently, gently.”

    Listen at 12:57

  16. Jim Crameron Technology sectorPositive15:08

    Technology has regained market leadership after recent underperformance.

    “tech has regained a leadership position in this market”

    Listen at 15:08

  17. Jim Crameron IPO market reopeningPositive17:35

    Reduced Iran uncertainty coincided with lower energy prices, rates, and IPO reopening.

    “As of as we got past the point of. peak uncertainty with Iran, energy prices and interest rates subsided, and we even started to see the IPO market reopening.”

    Listen at 17:35

  18. Jim Crameron AI memory supply shortageNegative19:56

    Memory production capacity could take years to resolve AI-related shortages.

    “It could take years to build enough production capacity to solve this shortage.”

    Listen at 19:56

  19. Jim Crameron Memory stocksPositive20:23

    Memory stocks remain supported by constrained supply and exceptionally strong demand.

    “for now, this group is very much still working because there just isn't a lot of supply coming on, and the demand is the strongest I've ever seen.”

    Listen at 20:23

  20. Jim Crameron Memory supplyNegative20:32

    Substantial additional memory supply will not arrive over 18 months.

    “Over the next 18 months, I don't see any supply coming off of any substance.”

    Listen at 20:32

  21. Jim Crameron Fiber-optic networkingPositive23:22

    The networking-stock rally reflects migration from copper to faster, cooler fiber optics.

    “These rallies are all about the move from copper-based networking solutions to fiber optics, which are faster and carry less heat.”

    Listen at 23:22

  22. Jim Crameron Technology-stock rallyMixed24:33

    Recent technology-stock leadership is driven by shortages rather than broad economic demand.

    “This is really driven by shortages, not by broad-based economic strength and demand.”

    Listen at 24:33

  23. Jim Crameron Data-center technology stocksPositive24:37

    Data-center strength may keep these technology groups leading markets.

    “as long as the data center buildup remains strong, we might have to get used to these groups of stocks leading the way.”

    Listen at 24:37

  24. Jim Crameron CoreWeavePositive25:08

    CoreWeave is a highly aggressive purchase.

    “CoreWeave is what I regard as being... A very aggressive buy.”

    Listen at 25:08

  25. Jim Crameron CoreWeaveNegative25:14

    CoreWeave has weak fundamentals, substantial debt, and likely high volatility.

    “I don't think the fundamentals are terrific. But remember, this is a new company with lots of debt and it's going to be prone to these kinds of up and down moves.”

    Listen at 25:14

  26. Jim Crameron Salesforce developmentsPositive26:06

    Mark Benioff’s discussed Salesforce developments will occur by 2030.

    “what Mark's talking about is stuff that will happen by 2030.”

    Listen at 26:06

  27. Jim Crameron SalesforcePositive26:18

    Investors should not sell Salesforce at its current price.

    “I would not sell it at these prices.”

    Listen at 26:18

  28. Jim Crameron Applied Materials, Lam Research, and KLAPositive26:40

    Applied Materials, Lam Research, and KLA can alleviate semiconductor shortages.

    “They're all good because they are the only way we can alleviate the shortages that we're seeing in semiconductors.”

    Listen at 26:40

  29. Rob Barrowson DT120Positive29:12

    About half of patients achieved remission 12 weeks after a single dose.

    “12 weeks later, about half of patients were in clinical remission.”

    Listen at 29:12

  30. Rob Barrowson DT120Positive29:43

    A single monitored dose produces months of response and remission for most patients.

    “A single dose of drug in a monitored clinical setting. And then we see months of clinical response and remission in a majority of patients.”

    Listen at 29:43

  31. Rob Barrowson FDA Priority Review Voucher ProgramPositive33:00

    The voucher could reduce breakthrough-drug FDA review from six months to one or two.

    “It takes that from even for breakthrough products, it's a six month review cycle and tries to bring that down to one or two months.”

    Listen at 33:00

  32. Rob Barrowson Psychedelic-drug DEA schedulingPositive33:13

    The executive order can accelerate DEA scheduling by at least three months.

    “It also has the ability with the DEA process to speed up scheduling by as much as three or more months.”

    Listen at 33:13

  33. Rob Barrowson Psychedelic treatmentsPositive33:40

    Historical psychedelic research indicates applicability across several mental-health and substance-use disorders.

    “what we've seen in historical research are broad applicability to anxiety, depression, to PTSD and to use disorders.”

    Listen at 33:40

  34. Jim Crameron AESPositive36:01

    AES appears undervalued and is worth buying.

    “It tastes incredibly cheap. I would be a buyer of it.”

    Listen at 36:01

  35. Jim Crameron InterDigitalPositive36:56

    InterDigital is attractive at current levels.

    “I like it. I like it a lot.”

    Listen at 36:56

  36. Investors should take profits in Infineon and repurchase at lower prices.

    “I think you take a little profit and you can buy it back lower.”

    Listen at 37:20

  37. Jim Crameron NetScoutMixed37:40

    NetScout appears to be forming a bottom despite limited appeal.

    “it's an interesting cloud security platform, frankly. It's not my cup of tea, but it looks like it's bottoming.”

    Listen at 37:40

  38. Jim Crameron FlexNegative38:20

    Flex is too expensive to recommend at current levels.

    “I just can't recommend it here. It's too high.”

    Listen at 38:20

  39. Jim Crameron BiogenPositive38:56

    Biogen appears attractive, and Gilead is also favored.

    “It looks pretty darn good. I also like Gilead, for that matter.”

    Listen at 38:56

  40. Johnson & Johnson may be the best or second-best drug stock.

    “We're buying what may be the best drug stock or at least second best if you're Eli Lilly.”

    Listen at 40:02

  41. Jim Crameron Johnson & Johnson psoriasis treatmentPositive41:30

    Johnson & Johnson’s psoriasis treatment is more convenient as a pill than injections.

    “J&J, on the other hand, has got a pill. Much more convenient.”

    Listen at 41:30

  42. Johnson & Johnson’s planned breakup will unlock value.

    “the breakup will help unlock value.”

    Listen at 42:40

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Books & mentions

Some links are affiliate links — PodLume may earn a commission if you buy.

Weekly email

State of the Pod, every Monday

The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.

Listen to the full episode and explore every guest, topic, and moment on PodLume.